NervGen Pharma’s NVG-291 Delivers Breakthrough Results in Chronic Spinal Cord Injury Treatment: Clinical Trial Success and FDA Approval Pathways
NervGen Pharma's NVG-291 therapy shows breakthrough results in restoring function for chronic…
NervGen Pharma Unveils Breakthrough NVG-291 Data: Hope for Chronic Spinal Cord Injury Recovery
NervGen Pharma's NVG-291 shows durable recovery in chronic spinal cord injury patients…
FDA Commissioner and Senator Pledge Sweeping Reforms to Overhaul Unreliable Drug Supply from India
FDA Commissioner Robert Califf and Sen. Bill Cassidy promise major reforms to…
FDA Grants Emergency Use Authorization for Antiparasitic Drug to Combat New World Screwworm in Cats
FDA grants emergency use authorization for antiparasitic ScrewBan-feline to treat New World…
H5N1 Bird Flu Outbreak Expands to Dairy Cows in Three More US States as FDA Issues Milk Safety Alert
FDA confirms H5N1 bird flu in dairy cows in Idaho, Michigan, Ohio.…
FDA Grants Emergency Approval for RSV Preventive Antibody for High-Risk Infants Amid Record Winter Surge
FDA approves nirsevimab, a monoclonal antibody RSV preventive for high-risk infants, as…
FDA Orders Urgent Recall of NutriBaby Formula After Salmonella Sickens 12 Infants in Midwest Outbreak
FDA recalls NutriBaby formula after salmonella outbreak sickens 12 Midwest infants. Parents…
FDA Approves Breakthrough mRNA Flu Vaccine with 90% Efficacy Against Influenza Strains
FDA approves Modera's mRNA flu vaccine with 90% efficacy, fast-tracked for surging…
FDA Approves Updated Flu Vaccine Targeting Dominant H3N2 Strain Amid Surging Outbreaks
FDA approves emergency reformulated flu vaccine against dominant H3N2 strain as outbreaks…
FDA Expands Ozempic Warnings on Heart Risks After Landmark Semaglutide Study Links Drug to Cardiovascular Events
FDA updates Ozempic labels after study shows 27% higher heart risks from…
